IRIS
PERLINI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.771
EU - Europa 3.329
AS - Asia 2.027
OC - Oceania 19
SA - Sud America 8
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.740
CN - Cina 1.852
IE - Irlanda 1.145
UA - Ucraina 565
FI - Finlandia 437
DE - Germania 334
IT - Italia 299
SE - Svezia 211
GB - Regno Unito 127
FR - Francia 61
SG - Singapore 53
BE - Belgio 50
RU - Federazione Russa 40
JP - Giappone 36
CA - Canada 30
CZ - Repubblica Ceca 23
IN - India 22
IR - Iran 22
TR - Turchia 18
AU - Australia 15
ES - Italia 10
ID - Indonesia 9
HK - Hong Kong 8
AT - Austria 7
NL - Olanda 7
BR - Brasile 6
NZ - Nuova Zelanda 4
EU - Europa 3
GR - Grecia 3
LV - Lettonia 3
MU - Mauritius 3
RO - Romania 3
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
NO - Norvegia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
QA - Qatar 1
SL - Sierra Leone 1
TW - Taiwan 1
Totale 10.166
Salva come PNG Salva come JPEG
Città #
Chandler 1.222
Dublin 1.145
Jacksonville 726
Nanjing 549
Ashburn 292
Ann Arbor 243
Princeton 217
Nanchang 215
Lawrence 208
Wilmington 207
Shenyang 162
Hebei 160
Beijing 153
Helsinki 148
Medford 146
Changsha 132
Boardman 116
Jiaxing 110
Shanghai 82
Pavia 76
Tianjin 72
Milan 69
Hangzhou 68
New York 65
Woodbridge 51
Brussels 50
Norwalk 41
Singapore 38
Falls Church 36
Saint Petersburg 34
Tokyo 34
Verona 29
Fairfield 27
Los Angeles 26
Toronto 25
Brno 23
Seattle 23
Piscataway 18
Des Moines 16
Taizhou 16
Pune 15
Washington 13
Zhengzhou 13
Çanakkale 12
Auburn Hills 11
Jinan 11
Vicenza 11
Guangzhou 10
Houston 10
Ningbo 10
Kunming 9
Chicago 8
Cáceres 8
Munich 8
Orange 7
Semarang 7
Vienna 7
Rockville 6
Tappahannock 6
Cambridge 5
Lanzhou 5
Leawood 5
Ardabil 4
Falkenstein 4
Feira de Santana 4
Monmouth Junction 4
Motta Visconti 4
Redwood City 4
San Francisco 4
San Genesio Ed Uniti 4
Zanjan 4
Borås 3
Bovisio Masciago 3
Changchun 3
Clifton 3
Cordaleo 3
Dearborn 3
Fuzhou 3
Haikou 3
Magenta 3
Melbourne 3
Mykolayiv 3
Sacramento 3
Senago 3
Al Qatif 2
Alexandria 2
Andover 2
Bangalore 2
Bergamo 2
Berlin 2
Bientina 2
Buckinghamshire 2
Burwood 2
Caserta 2
Como 2
Curaçao 2
Desio 2
Elda 2
Grimstad 2
Henderson 2
Totale 7.374
Salva come PNG Salva come JPEG
Nome #
Treatment of chronic heart failure: an expert system advisor for general practitioners. 91
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 90
La simulazione su manichino migliora l’abilità degli studenti di Medicina nell’auscultazione cardiaca? L’esperienza di Pavia 82
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 82
Effect of chronic sympatectomy in a model of rat cardiac hypertrophy: role of the extracellular matrix. 81
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 81
Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. 78
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers. 77
Remote matrix metalloproteinases activation as systemic consequence pf liver injury: the role of lung. 77
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. 76
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 76
Simulation-guided cardiac auscultation improves medical students' clinical skills: the Pavia pilot experience 76
Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? 76
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 76
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis 75
Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? 75
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance 75
Interstitial fibrosis is blunted by chronic sympathectomy in experimental pressure-overload hypertrophy. 74
Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. 72
Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation. 71
Antiadrenergic effects of adenosine in pressure overload hypertrophy. 70
Adenosine 70
Experience from controlled trials of physical-training in chronic heart-failure-protocol and patient factors in effectiveness in the improvement in exercise tolerance 69
Adenosine A1 and A2A receptor cross-talk during ageing in the rat myocardium 69
Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. 69
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 69
Lack of contribution of autonomic influences to vascular nitric oxide release? Studies in the unanesthetized rat. 67
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. 67
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 67
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure 66
Effects of the chronic digoxin administration on extracellular matrix turnover in a model of cardiac hypertrophy in Guinea pigs. 66
Right ventricular function in AL amyloidosis: characteristics and prognostic implication 64
Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis 64
Reproducibility of ultrasound assessment of common carotic and femoral artery compliance and distensibility in the anesthetized rat. 63
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 63
Assessment of regional myocardial performance with end-systolic pressure lenght and thickness relationships. 62
Analisi preliminare di un sistema esperto per la diagnosi cardiologica incruenta. 61
Semplice algoritmo per la valutazione del rilasciamento isovolumetrico del ventricolo sinistro. 61
Le alterazioni della dinamica del riempimento ventricolare sinistro predicono la progressione dell'ipertrofia ventricolare sinistra verso l'insufficienza cardiaca. 61
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 61
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis 61
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 61
Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening 60
Enhanced vascular reactivity in the sympathectomized rat: studies in vivo and in small isolated resistance arteries 59
Matrix metalloproteinases: analysis of the activity in Guinea pig cardiac hypertrophy. 59
Ultrasonic integrated backscatter as a useful and tool to noninvasively study myocardial function and fibrosis in hypertensive heart disease 58
Nonischemic end-systolic performance. Effects of alterations in regional and global left ventricular contractility. 58
Dolore Toracico. 58
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 58
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. 58
Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers 58
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 58
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System 58
The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44 58
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 58
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 58
Metalloproteasi di matrice e progressiva disfunzione diastolica del cuore ipertrofico. 57
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis 57
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy 57
Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats 57
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 57
Confronto tra apicografia calibrata e tecniche invasive della valutazione della diastole: dati preliminari. 57
Contribution of the dynamic phonomechanocardiography to the valvular heart disease diagnosis: an expert system study. 55
Evidence for an intrinsic mechanism regulating the heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 55
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL amyloidosis 55
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 55
Effects of a Bioavailable Arabinoxylan-enriched White Bread Flour on Postprandial Glucose Response in Normoglycemic Subjects 54
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 54
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 54
Determinants of respiratory sinus arrhythmia in the vagotomized rabbit. 53
Measuring left ventricular dimensions by conductance catheter in the rabbit. 53
Prevalence and Prognostic Value of Conduction Disturbances at the Time of Diagnosis of Cardiac AL Amyloidosis 53
Modificazioni dell'impulso apicale in condizioni di sovraccarico acuto di volume. 53
Critical evaluation of pharmaco-dynamic tests for cardiovascular diagnosis: an expert system approach. 53
NT-proBNP and the risk of incident hypertension: Is change over time a better predictor than baseline value? 53
The potential advantage of omapatrilat: dual anti-fibrotic and antiinflammatory effects in one single molecule 52
Durante occlusione coronarica sperimentale la dobutamina rallenta ulteriormente la costante di tempo del rilasciamento isovolumetrico. 52
Hypertensive heart disease: diagnostic and therapeutic guidelines.Commissione congiunta Società Italiana dell'lpertensione Arteriosa; Società Italiana di Cardiologia; Associazione Nazionale Medici Cardiologi Ospedalieri. 52
Diagnostic and Prognostic Value of Low QRS Voltages in Cardiac AL Amyloidosis 52
Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. 52
As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis 52
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 52
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 52
Comparative analysis of a 4-lead portable smartphone based electrocardiograph versus standard 12-lead electrocardiograph for cardiovascular screening in low-income settings 52
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 52
Dynamic right and left ventricular interaction in tne rabbit: simultaneous measurements of ventricular pressure-volume loops. 51
Pavia senza doloreUn legame tra ospedale e territorio 51
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 51
Modelli matematici per lo studio del rilasciamento isovolumetrico. 51
RENIN-ANGIOTENSIN SYSTEM AND ATRIAL FIBRILLATION 51
Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy 51
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 51
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 51
Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events 50
Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? 50
La rilevanza diagnostica e prognostica del peptide natriuretico di tipo B (BNP) e del suo frammento N terminale (NT-proBNP) nei pazienti con amiloidosi AL e insufficienza renale 50
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 50
Sympathovagal interplay in the control of overall blood pressure variability in unanesthetized rats. 49
Effects of preload on regional nonischemic end-systolic performance 49
Influence of residual ischaemia on heart rate variability after myocardial infarction. 49
Totale 6.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.159 648 849 14 109 5 110 27 113 5 168 95 16
2020/20211.218 147 106 67 116 11 139 22 197 66 174 143 30
2021/20221.009 19 15 37 16 38 36 31 71 61 30 151 504
2022/20233.367 376 238 51 294 347 346 3 184 1.376 17 89 46
2023/20241.247 163 199 47 84 113 291 36 74 10 59 75 96
2024/202575 75 0 0 0 0 0 0 0 0 0 0 0
Totale 10.394